Ranbaxy Laboratories Ltd has announced the Unaudited results for the quarter ended March 31, 2007.
The Company has posted a profit after tax of Rs 1152.80 million for the quarter ended March 31, 2007 as compared to Rs 502.40 million for the quarter ended March 31, 2006. Total Income (net of excise) has increased from Rs 8146.50 million for the quarter ended March 31, 2006 to Rs 10160.40 million for the quarter ended March 31, 2007.
The Unaudited Consolidated results (as per Indian GAAP) are as follows: The Group has posted a profit after tax & minority Interests of Rs 1276 million for the quarter ended March 31, 2007 as compared to Rs 714 million for the quarter ended March 31, 2006. Total Income (net of excise) has increased from Rs 12977 million for the quarter ended March 31, 2006 to Rs 15866 million for the quarter ended March 31, 2007.
The stock closed the day at Rs.369.95, down by Rs.2.20 or 0.59%. The total traded quantity was 647631 compared to 2 week average of 465909. The stock hit an intraday high of Rs.376 and intraday low of Rs.362.55.